175 related articles for article (PubMed ID: 33322063)
21. An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S13-8. PubMed ID: 21654265
[TBL] [Abstract][Full Text] [Related]
22. Clinical efficacy and safety of topiroxostat in Japanese male hyperuricemic patients with or without gout: an exploratory, phase 2a, multicentre, randomized, double-blind, placebo-controlled study.
Hosoya T; Sasaki T; Hashimoto H; Sakamoto R; Ohashi T
J Clin Pharm Ther; 2016 Jun; 41(3):298-305. PubMed ID: 27079434
[TBL] [Abstract][Full Text] [Related]
23. A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia.
Xu S; Liu X; Ming J; Chen S; Wang Y; Liu X; Liu H; Peng Y; Wang J; Lin J; Ji H; Liu B; Lu Y; Liu P; Zhang Y; Ji Q
Int J Rheum Dis; 2015 Jul; 18(6):669-78. PubMed ID: 26013187
[TBL] [Abstract][Full Text] [Related]
24. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia.
Huang X; Du H; Gu J; Zhao D; Jiang L; Li X; Zuo X; Liu Y; Li Z; Li X; Zhu P; Li J; Zhang Z; Huang A; Zhang Y; Bao C
Int J Rheum Dis; 2014 Jul; 17(6):679-86. PubMed ID: 24467549
[TBL] [Abstract][Full Text] [Related]
25. Effects of Febuxostat in Early Gout: A Randomized, Double-Blind, Placebo-Controlled Study.
Dalbeth N; Saag KG; Palmer WE; Choi HK; Hunt B; MacDonald PA; Thienel U; Gunawardhana L
Arthritis Rheumatol; 2017 Dec; 69(12):2386-2395. PubMed ID: 28975718
[TBL] [Abstract][Full Text] [Related]
26. Uric acid-lowering and renoprotective effects of topiroxostat, a selective xanthine oxidoreductase inhibitor, in patients with diabetic nephropathy and hyperuricemia: a randomized, double-blind, placebo-controlled, parallel-group study (UPWARD study).
Wada T; Hosoya T; Honda D; Sakamoto R; Narita K; Sasaki T; Okui D; Kimura K
Clin Exp Nephrol; 2018 Aug; 22(4):860-870. PubMed ID: 29372470
[TBL] [Abstract][Full Text] [Related]
27. An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 2 exploratory clinical study.
Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S44-9. PubMed ID: 21654269
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the safety and efficacy of a Fuling-Zexie decoction for people with asymptomatic hyperuricemia: protocol for a prospective, double-blinded, randomized, placebo-controlled clinical trial.
Yan J; Zhou Y; Yang Q; Wu J; He X
Trials; 2022 Jun; 23(1):517. PubMed ID: 35725639
[TBL] [Abstract][Full Text] [Related]
29. A comparative study of efficacy and safety of febuxostat and allopurinol in pyrazinamide-induced hyperuricemic tubercular patients.
Pichholiya M; Yadav AK; Luhadia SK; Tahashildar J; Aseri ML
Indian J Pharmacol; 2016; 48(5):522-525. PubMed ID: 27721537
[TBL] [Abstract][Full Text] [Related]
30. Effect of apple polyphenols on vascular oxidative stress and endothelium function: a translational study.
Cicero AFG; Caliceti C; Fogacci F; Giovannini M; Calabria D; Colletti A; Veronesi M; Roda A; Borghi C
Mol Nutr Food Res; 2017 Nov; 61(11):. PubMed ID: 28755406
[TBL] [Abstract][Full Text] [Related]
31. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
[TBL] [Abstract][Full Text] [Related]
32. Effect of Oral Vitamin C Supplementation on High-Altitude Hyperuricemia in Young Men Initially Migrating to High Altitude: A Pilot Study.
Peng H; Feng D; Wang Y; Dong Z; Chen Q; Zhang L; Luo R; Chen J; Wang A; Ma S
High Alt Med Biol; 2018 Dec; 19(4):373-381. PubMed ID: 30358417
[TBL] [Abstract][Full Text] [Related]
33. Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial.
Asemi Z; Khorrami-Rad A; Alizadeh SA; Shakeri H; Esmaillzadeh A
Clin Nutr; 2014 Apr; 33(2):198-203. PubMed ID: 23786900
[TBL] [Abstract][Full Text] [Related]
34. Traditional Chinese medicine in the treatment of patients with hyperuricemia: A randomized placebo-controlled double-blinded clinical trial.
Leong PY; Chen HH; Gau SY; Chen CY; Su YC; Wei JC
Int J Rheum Dis; 2024 Jan; 27(1):e14986. PubMed ID: 38014453
[TBL] [Abstract][Full Text] [Related]
35. Evaluating the effectiveness and safety of acupuncture on serum uric acid in asymptomatic hyperuricemia population: a randomized controlled clinical trial study protocol.
Yu LL; Li CN; Fang MY; Ma Y; Wang B; Lin FP; Liu WH; Tu SH; Chen Z; Xie WX; Zhang RY; Huang Y; Zheng CH; Wang Y
Front Endocrinol (Lausanne); 2023; 14():1218546. PubMed ID: 37900149
[TBL] [Abstract][Full Text] [Related]
36. Is rasburicase an effective alternative to allopurinol for management of hyperuricemia in renal failure patients? A double blind-randomized study.
De Angelis S; Noce A; Di Renzo L; Cianci R; Naticchia A; Giarrizzo GF; Giordano F; Tozzo C; Splendiani G; De Lorenzo A
Eur Rev Med Pharmacol Sci; 2007; 11(3):179-84. PubMed ID: 17970234
[TBL] [Abstract][Full Text] [Related]
37. The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial.
Huang HY; Appel LJ; Choi MJ; Gelber AC; Charleston J; Norkus EP; Miller ER
Arthritis Rheum; 2005 Jun; 52(6):1843-7. PubMed ID: 15934094
[TBL] [Abstract][Full Text] [Related]
38. Effect of oral vitamin C supplementation on serum uric acid: a meta-analysis of randomized controlled trials.
Juraschek SP; Miller ER; Gelber AC
Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1295-306. PubMed ID: 21671418
[TBL] [Abstract][Full Text] [Related]
39. Can soy intake affect serum uric acid level? Pooled analysis from two 6-month randomized controlled trials among Chinese postmenopausal women with prediabetes or prehypertension.
Liu ZM; Ho CS; Chen YM; Woo J
Eur J Nutr; 2015 Feb; 54(1):51-8. PubMed ID: 24659208
[TBL] [Abstract][Full Text] [Related]
40. Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial.
Kimura K; Hosoya T; Uchida S; Inaba M; Makino H; Maruyama S; Ito S; Yamamoto T; Tomino Y; Ohno I; Shibagaki Y; Iimuro S; Imai N; Kuwabara M; Hayakawa H; Ohtsu H; Ohashi Y;
Am J Kidney Dis; 2018 Dec; 72(6):798-810. PubMed ID: 30177485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
